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DELIVERY SYSTEM FOR A COMPOSITION

The present invention addresses the identi?ed need in the
art by providing a cutaneous delivery system for a compo
sition, comprising an ordered nanoporous membrane and a
reservoir in ?uid communication With the membrane. The
nanoporous membrane of the present invention can be
functionaliZed in a variety of Ways at the pore openings to

This application is a continuation of US. patent applica
tion Ser. No. 11/128,443 ?led on May 13, 2005, Which
claims the bene?t of Provisional Patent Application Ser. No.
60/570,927 ?led on May 13, 2004, the disclosures ofeach of
Which are incorporated herein in their entirety by reference.

impart selectivity to the membrane, to provide a selectively
gateable membrane as Well as other functions. A cutaneous

TECHNICAL FIELD

delivery device for a composition is provided also. In one
embodiment, the cutaneous delivery device is adapted to
deliver the composition selectively in response to an elec

The present invention relates to devices and methods for

cutaneous delivery of a composition. Speci?cally, the inven

trical impulse.

tion relates to devices and methods for cutaneous delivery of
a composition using ordered nanoporous membranes com

SUMMARY OF THE INVENTION

prising aligned nanotubules embedded in a polymer matrix.
The membranes of the present invention can be functional

In accordance With the purposes of the present invention
as described herein, a device is provided for cutaneous

iZed for selective transport of the composition.
BACKGROUND OF THE INVENTION
20

Cutaneous patches, such as transdermal patches, are

popular methods of non-invasive controlled release drug
delivery. Additional uses of patch technology include appe
tite stimulation and/or suppression, for Weight increase/
maintenance or control. Advantages of transdermal delivery
include avoidance of gastrointestinal side-effects, avoidance

suitable structure used as a reservoir, such as a receptacle
25

drug levels for up to one Week, reduction of drug peak
30

ery systems are currently available for nicotine (over the

counter formulations by various manufacturers), clonidine

impregnated With the composition, or the like. It Will be
appreciated also that the composition may be provided in a
variety of physical forms, including but not limited to a
liquid, a gel, or any other suitable physical form. The device
may further include a supplemental membrane, Wherein the
ordered nanoporous membrane is interposed betWeen the

reservoir and the supplemental membrane. The supplemen
tal membrane may include, or be in contiguous contact With,
a suitable adhesive for adhering the device to a surface such

(for example, CATAPRES), and fentanyl (for example,
DURAGESIC).
Currently available transdermal delivery systems are

nanotubules and a reservoir in ?uid communication With the
ordered nanoporous membrane. The reservoir may be any

containing the composition, a porous matrix releasably

of the hepatic ?rst-pass e?fect, maintenance of therapeutic
related side effects, improved patient compliance, and easy
termination of drug input. Example transdermal drug deliv

delivery of a composition, comprising an ordered nanopo
rous membrane including a plurality of aligned holloW

as skin.
35

The ordered nanoporous membrane may be formed by

aligning the plurality of holloW nanotubules, coating the

effective for their intended purposes, but Would bene?t from

improvements. For example, it is knoWn that nicotine

aligned holloW nanotubules With a continuous polymer

replacement smoking cessation therapy is improved by

matrix to form a membrane, and etching the membrane to
open the plurality of holloW nanotubules and form pores.
The etching step may also oxidiZe an end of the nanotubules
to form carboxylate groups. In one embodiment, the ordered
nanoporous membrane may be selectively etched to shorten
the plurality of nanotubules to a length that is less than a

delivering nicotine at a similar rate as Would be derived by

smoking a cigarette, Which results in peaks in plasma
nicotine and improved satisfaction of cravings (BenoWitZ et
al., Sources of variability in nicotine and cotinine levels With

40

use of nicotine nasal spray, transdermal nicotine, and ciga

rette smoking, Brit. J. ofClin. Pharm. (1997) 43, 259-267;
Russell, Nicotine replacement: the role of blood nicotine
levels, their rate of change, and nicotine tolerance, In:

45

dimension of the polymer matrix, thereby improving ?ux by
reducing the distance traveled by the composition. Typically,
the ordered nanoporous membrane is selectively etched by
electrochemical oxidation, although it Will be appreciated
that any suitable etching technique may be utiliZed, With the

Pomerleau et al., eds., Nicotine replacement: a critical

evaluation, NeW York: Alan R. Liss, 1988, 187-217). HoW

proviso that the nanotubules are selectively shortened to a

ever, conventional nicotine patches deliver nicotine at a
50

greater degree than the polymer matrix.

are therefore less effective (Gourlay et al., Double blind trial

The ordered nanoporous membrane typically also

of repeated treatment With transdermal nicotine for relapsed

55

includes at least one additional functional unit bound adja
cent the nanotubule pore, Which may selectively expose or
at least partially occlude the pore. The additional functional
unit may include at least one available amine group for

constant rate resulting in steady plasma nicotine levels, and

smokers, BMJ (1995) 311, 363-6).
As another example, use of clonidine during opiate With

draWal therapy often requires an extremely complex dosing
regimen. Current transdermal patch technologies cannot
easily be adapted to such dosing regimens, and accordingly

binding to the nanotubule end carboxylate group. The at
least one additional functional group may be selected from
the group consisting of a ligand, a receptor, a receptor-ligand

oral clonidine therapy is much more common. Delivery of

clonidine therapy via a transdermal delivery system capable

of providing a complicated, staggered dosage regimen

60

Would alloW less medical supervision, decreasing health

ci?cally binding to a predetermined target molecule, a
hydrophilic molecule, a hydrophobic molecule, a catalytic
coordination compound, a catalytic metal, biotin, avidin,

care costs. Still further, a programmable transdermal deliv

ery system Would alloW ?exibility in delivery and With
draWal rates for the drug, alloWing ?exibility in dose titra
tion during delivery and also during WithdraWal from the
drug, reducing the rebound effects associated With clonidine
Withdrawal.

complex, a reversibly binding receptor-ligand complex, a
charged molecule, a binder-ligand complex, a reversibly
binding binder-ligand complex, a ligand adapted for spe

65

streptavidin, aliphatic amines, charged dyes, anionically
charged ligands, cationically charged ligands, or any com
bination.
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In one embodiment, the additional functional unit
includes a charged group, and selectively exposes or at least
partially occludes the pore of an adjacent nanotubule in
response to an electrical impulse. In this embodiment, the

In one embodiment, the additional functional unit may
include a charged group, and selectively exposes or at least

partially occludes the pore of an adjacent nanotubule in
response to an electrical impulse. In that embodiment, the

nanotubule is typically electrically conductive, and the poly

nanotubules are typically electrically conducting and the
continuous polymer matrix is typically electrically insulat
ing, Whereby the effect of the electrical impulse is substan
tially restricted to the plurality of nanotubules. The device

mer matrix is typically electrically insulating. The additional
functional unit may be selected from the group consisting of

acetate, aluminate, amino sulfonate, ammonium, quaternary
ammonium, arsenate, aZide, carbonate, borate, bromate,

may further include at least one contact in electrical com

bromite, carbide, chlorite, chromate, chromite, cyanate,
dichromate, phosphate, phosphite, disul?de, formate, fulmi
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate,
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate,

munication With the ordered nanoporous membrane, and an
actuator in electrical communication With the at least one
contact. It Will be appreciated that the actuator may be as
simple as a sWitch for delivering an electrical impulse, or
may be a programmable actuator such as a microchip, to

charged metal coordination compounds, or combinations
thereof.
The method may further include the step of providing at

alloW initiation and termination of the electrical impulse at

predetermined intervals.
In this embodiment, the additional functional unit may be
selected from the group of charged groups consisting of

acetate, aluminate, amino sulfonate, ammonium, quaternary
ammonium, arsenate, aZide, carbonate, borate, bromate,

20

bromite, carbide, chlorite, chromate, chromite, cyanate,
dichromate, phosphate, phosphite, disul?de, formate, fulmi
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate,
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate,

25

least one contact in electrical communication With the
ordered nanoporous membrane. An actuator in electrical
communication With the at least one contact may also be
provided. As noted above, the actuator may be as simple as
an on-olf sWitch, or may be a programmable system such as
a microchip controlling a poWer source.

It should be appreciated that the embodiments shoWn and
described herein are an illustration of one of the modes best

charged metal coordination compounds, or any combination

suited to carry out the invention. It Will be realiZed that the

thereof in accordance With the desired function. The nano

invention is capable of other different embodiments and its
several details are capable of modi?cation in various, obvi
ous aspects all Without departing from the invention.

tubules may be selected from the group consisting of multi

Walled carbon nanotubes, single-Walled carbon nanotubes,
self-assembling macromolecular tubules comprising pep

30

tides and porphyrins, or any combination thereof.

Accordingly, the draWings and descriptions Will be regarded
as illustrative in nature, and not as restrictive.

In another aspect of the present invention, a method for
cutaneous delivery of a composition is provided, comprising
providing a reservoir containing the composition in ?uid
communication With an ordered nanoporous membrane

BRIEF DESCRIPTION OF THE DRAWINGS
35

comprising a plurality of holloW nanotubules and passing
the composition through the ordered nanoporous membrane.
As described above, the ordered nanoporous membrane may

explain the principles of the invention. In the draWings:

be formed by aligning the plurality of holloW nanotubules,
coating the aligned holloW nanotubules With a continuous
polymer matrix to form a membrane, and etching the mem
brane to open the plurality of holloW nanotubules and form
pores. The etching step may further oxidiZe an end of the
nanotubules to form carboxylate groups. The membrane
may further be selectively etched to shorten the plurality of
nanotubules to a length that is less than a dimension of the

40

45

50

partially occlude the pore. Typically, functional units includ

55

nanotubule pores by a charged functional group (amino
sulfonate) using application of a positive or a negative bias;
FIG. 4 schematically depicts a tether molecule comprising
a series of polypeptide links, Wherein length is controlled by
successive carboimide reactions at a nanotubule (n) pore;
FIG. 5 shoWs transport of methylviologen2+ across a

ing an available amine group to bind to the nanotubule end
carboxylate group are selected. The at least one additional

nanotubule membrane functionaliZed With anionic dye
coupled to a tether molecule (see FIG. 4) consisting of 2

polypeptide links;
FIG. 6 schematically depicts an embodiment of a cuta

functional group may be selected from the group consisting
of a ligand, a receptor, a receptor-ligand complex, a revers
60

binder-ligand complex, a reversibly binding binder-ligand
complex, a ligand adapted for speci?cally binding to a
predetermined target molecule, a hydrophilic molecule, a
hydrophobic molecule, a catalytic coordination compound, a

charged ligands, and any combination thereof.

FIG. 2 shoWs ?ux of nicotine through a polymer mem
brane/ skin composite With and Without the ordered nanotu
bule membrane of the present invention;

FIG. 3 schematically depicts the opening and closing of

selectively etched Whereby the nanotubules are shortened as
noted above.
The method may further include the step of binding an
additional functional unit adjacent the nanotubule pore. The
additional functional unit may selectively expose or at least

catalytic metal, biotin, avidin, streptavidin, aliphatic amines,
charged dyes, anionically charged ligands, cationically

FIG. 1 shoWs ?ux of nicotine through the ordered nano
tubule membrane of the present invention as a function of

nanotubule tip functionaliZation;

polymer matrix. Any suitable method for etching the mem
brane may be selected, including but not limited to electro
chemical oxidation, With the proviso that the membrane is

ibly binding receptor-ligand complex, a charged molecule, a

The accompanying draWings incorporated in and forming
a part of the speci?cation, illustrate several aspects of the
present invention and together With the description serve to

65

neous delivery system, Wherein delivery of a composition is
effected by application of an electrical impulse; and
FIG. 7 schematically depicts various molecules useful in
functionaliZing the ordered nanoporous membrane of the

present invention With charged molecules: (711) long chain
amino sulfonate; (7b) short chain amino sulfonate; (7c)
schematic depiction of a charged triphenylphosphonium
molecule having added chain lengths; (7d) schematic depic
tion of attachment of a charged thiol-gold nanocrystal mol
ecule.

US 7,229,556 B1
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buffer pH 7.4 to 1 mL with acetonitrile. Samples were
centrifuged at 3500><g for 5 min, and the supernatant was

Reference will now be made in detail to the present

preferred embodiment of the invention, an example of which
is illustrated in the accompanying drawings.

analyZed by reversed-phase HPLC (Perkin-Elmer Series 200
pump, autosampler, Brownlee Spheri5 VL C18 5 pm column
with RP-18 7 pm guard column, 785A UV/VIS detector set
at 259 nm, and Turbochrom 6.1.2 software). The mobile
phase was acetonitrile and pH 5.5 acetate buffer (70:30). The

DETAILED DESCRIPTION OF THE
INVENTION

The following examples are presented in support of and to

acetate buffer was 0.05 M sodium acetate anyhydrous and

further illustrate the invention as described herein. However,
the invention is not to be considered as limited thereto. The

0.25% triethylamine. Flow rate was 1 ml/minute, and injec
tion volume was 20 pl.
As shown in FIG. 1, a ?ux of 17 p.mol/cm2~hr was
achieved using a membrane having non-functionaliZed CNT

patents, patent applications, and citations of literature
referred to herein are understood to form a part of this

disclosure, and are incorporated in their entirety by refer

tips, which compares favorably with conventional transder
mal patch delivery rates of 2-6 umol/hr for steady state
delivery with increased rate requirements up to 20 umol/hr
for desired peaks in drug levels that simulate smoking.
Typical transdermal patches are 5-25 cm2 in siZe, resulting

ence.

EXAMPLE 1

Ordered nanoporous membranes were prepared substan

tially as described in US. patent application Ser. No. 11/ 128,
443, ?led on May 13, 2004. Aligned carbon nanotubes
(CNTs) were grown in situ using substantially the methods
described in R. Andrews et al., Continuous production of
aligned carbon nanotubes: a step closer to commercial

realiZation, Chem. Phys. Le”. (1999) 303, 467-474, on
quartz substrate using a ferrocene-xylene-argon-hydrogen

in a ?exible required nicotine ?ux rate range of 0.08-4
20

tions in water [Zorin et al., In vitro test of nicotine’s

permeability through human skin. Risk evaluation and
25

percent solution of polystyrene (PS) and toluene was spin

30

quartz substrate, to produce a freestanding composite ?lm of
5 to 10 um thickness.
A thin layer of excess polymer from the top surface was
then removed to open the CNT tips and form the pores of a
membrane structure. This was accomplished with H2O
plasma-enhanced oxidation process at conditions similar to

35

faster than CNTs; thus, the CNT tips were 10 to 50 nm above
40

nicotine through the membrane could be controllably
reduced using long chain alkanes. FunctionaliZation of the
was 2.4 nm in length, the resultant CNT pore diameter was

expected to be 2.7 nm (7.5 nm—4.8 nm). The CNT cross
section surface area was reduced by a factor of 7.5, which
was very close to the experimentally observed ?ux reduc
tion.
It will be appreciated, as discussed and described in

greater detail in US. patent application Ser. No. 11/128,443,

variety of functional molecules, with the proviso that the
molecule is amine-terminated to allow binding to the nano

The physical, chemical, and biomolecule transporting
45

tubule carboxylate group. Accordingly, longer or shorter
chain molecules may be provided to increase or decrease
?ux rate as desired, by occluding the nanotubule pores to a

greater or lesser degree in accordance with the properties of
the composition to be transferred, such as molecular siZe. As

groups. Transport of nicotine through membranes containing
non-functionaliZed CNT tips was compared to membranes

rather the ordered nanoporous membrane is expected to
control the input rate.
Referring again to FIG. 1, it was shown that ?ux rate of

that the foregoing synthesis conditions are applicable to a

ready to react with amine-terminated biomolecules as will
be discussed below.

properties of the membranes are described in greater detail
in US. patent application Ser. No. 11/ 128,443. As described
therein, the membrane nanotubule tips of this invention can
be functionaliZed with a variety of additional functional

safety aspects, Ann. Occup. Hyg. 43 (1999) 405-413].
Accordingly, skin is not expected to be the rate-limiting step
to transport of a composition in the present invention, but

CNT tips with octadecyl amine reduced the ?ux rate to 2.7
umol/cm2~hr, or a factor of 6.2. Since the long chain amine

conditions used to remove Fe nanocrystal catalyst particles
from the CNT tips. The plasma oxidation process etched PS

the polymer surface. The plasma oxidation process also left
the tips of the CNTs functionaliZed with carboxylate groups,

for nicotine ?ux in human skin, as rates as high as 8.3

umol/cm2~hr have been reported from 50% nicotine solu

feed in a chemical vapor deposition process. A 50 weight
coated over the surface to impregnate the CNT array. The
?lm was dried in vacuum for 4 days, and hydro?uoric acid
was then used to remove the CNT-PS composite from the

umol/cm2~hr. This is well below published literature values

50

having CNT tips functionaliZed with long chain alkanes. To
functionaliZe the CNT membranes with long chain alkanes,

described in US. patent application Ser. No. 11/ 128,443, the
ordered nanoporous membrane may be selectively etched,
such as by electrochemical oxidation, to reduce the length of

the following conditions were used: 95.75 mg of EDC

the nanotubules to a greater degree than the width of the

(1 -ethyl-3 -(3-dimethylaminopropyl) carbodiimide hydro

polymer matrix, thereby shortening the diffusion path and

chloride), 195.24 mg 2-(N-morpholino)ethane sulfonic acid
(MES) buffer (pH 6.5), and 13.48 mg of octadecyl amine

55

were weighed and added to 10 cc of water to make a solution

It is common in the art to deliver certain compositions,
such as drugs, via a cutaneous patch. Such patches have been

having 50 mM EDC, 0.1 M MES, and 5 mM octadecyl
amine. The solution was ultrasonicated for 10-15 minutes.
Next, the membrane was immersed in the solution for 4
hours.
The CNT membrane was placed in a u-cell separating 10

increasing ?ux rate, without compromising membrane
strength or integrity.

found desirable for their convenience and ease of use. As
60

examples, three skin-permeable drugs often delivered by
cutaneous patch are nicotine (used in smoking cessation),

fentanyl (used in pain management), and clonidine (used in

UV detection. Analytical samples were prepared by diluting

opiate withdrawal and management of hypertension). The
molecular weight range for nicotine, fentanyl, and clonidine
is 162-336, with nicotine being the smallest and fentanyl the
largest. The drugs range in lipophilicity from log octanol/

250 pl of diffusion or standard samples in isotonic phosphate

water partition coef?cient values of 0.88-3.62, with nicotine

mg/ml of nicotine in pH 7.4 buffer solution from buffered
analyte solution. The concentration of nicotine in the analyte
solution as a function of time was quanti?ed by HPLC with

65
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8

being the most polar and fentanyl the least. It is known that
nicotine and fentanyl require fast input rates to achieve

skin have been reported at 2.6 mg/cm2~hr [Roy et al., 1990;
Michaels et al., AlChE 21 (1975) 985-996].

peaks in drug levels.

The ordered nanoporous membrane of the present inven

Conventional nicotine patches deliver 0.33 to 1 mg of
nicotine per hour, meaning that the target for constant rate

tion Was shoWn to provide a delivery rate for a composition
Well Within the necessary ranges for such compositions as

baseline delivery is 2-6 pmol/hr. A commercially marketed

nicotine, clonidine, and fentanyl in accordance With infor

nicotine spray delivers 1 mg of drug per dose, Which has a
53% bioavailability. Accordingly, a dose of 530 pg (3.3
pmol) must be delivered Within a short time frame. Selecting
a delivery period of 10 min as an example, the fast delivery
rate for peak nicotine levels Would be about 20 pmol/hr,
Which as seen from the foregoing disclosure is easily
attained by the ordered nanoporous membrane of the present
invention. Conventional nicotine transdermal patches are

mation derived from delivery rates of conventional cutane
ous patches. Attention Was therefore turned to adapting the

5-25 cm2 in siZe, resulting in a ?exible required nicotine ?ux

use as components of cutaneous delivery systems in com

rate range of 0.08-4 pmol/cm2~hr. Skin is unlikely to be a
rate-limiting factor, as ?ux rates as high as 8.3 pmol/cm2 hr
have been reported from 50% nicotine solutions in Water

bination With the ordered nanoporous membranes of the

(Zorin et al., 1999). Accordingly, the ordered nanoporous

mer/adhesive combinations providing the least di?‘usional
resistance. Four commercially-available polymer mem

membrane of the present invention can be expected to

ordered nanoporous membrane for use as a component of a

cutaneous patch.
EXAMPLE 2

Consideration Was given to supplemental membranes for

present invention. Potentially suitable polymer ?lms and
pressure sensitive adhesives Were evaluated to de?ne poly
20

reliably control the nicotine drug input rate to the body.

branes and three pressure sensitive adhesives Were consid
ered. The four membranes evaluated Were: (1) a copolyester

An example dynamic dosing regimen for oral clonidine
during opiate WithdraWal therapy is: 0.1 mg tWice daily on
day 1, thrice daily on day 2, and four times daily on days 3
and 4, thrice daily on days 5 and 6, tWice daily on days 7 and

membrane (MEDIFILM® 390; Mylan Technologies, Inc.,
25

8, and once daily on days 9 and 10. The oral bioavailability
of clonidine is 90% or less (decreased bioavailability With
multiple dosing), so the required transdermal regimen can be

(MEDIFILM® 840). The adhesives evaluated Were: (1) an
acrylic pressure sensitive adhesive having no functional
groups to prevent chemical interaction of drugs With adhe

expected to be 0.18 mg/d on day one, to a maximum rate of

0.36 mg/d, and then doWn to 0.09 mg/d by the end of the
treatment period [Frisk-Holmberg et al., Clonidine kinetics

30

sitive amine-compatible adhesive (BIO-PSA® 7-4303, Dow
Corning Co., Midland, Mich.); and (3) a silicone pressure
sensitive standard adhesive (BlO-PSA® 7-4606, DoW Com
35

The adhesives Were adhered to the different polymer

pressed onto pieces of hairless guinea pig skin. Skin samples
Were also tested With the same drug solution Without adhe
40

sive/polymer combinations. The membrane composites
Were placed into ?oW-through PermeGear diffusion cells at
320 C. (n:3), and nicotine in phosphate buffer Was applied

(1993) 591-600]. Assuming a 10 cm2 patch, the required

to the polymer surface. Experiments Were run for a 24 hr

period With a receiver solution of isotonic phosphate buffer
45

ordered membrane of the present invention.

solution pH 7.4 at a How rate of 5 mL/hr. Samples Were
collected every 3 hr using a fraction collector. Nicotine

concentration in collected samples Was determined by

As another example, commercially available fentanyl
patches used in pain management deliver constant rates of
25 to 100 pg/hr. The lag time across human skin is 12

ing).
membranes, and the adhesive/polymer combination Was

delivery rate range for a transdermal patch Would be 0.375
to 1.5 pg/cm2~hr to ensure that the skin Would not rate-limit

the drug delivery. Again, this delivery rate is Well Within the
delivery rate ranges achievable using the nanoporous

sive polymer (DURO-TAK® 87-900A, National Starch &
Chemical Co., BridgeWater, N.J.); a silicone pressure sen

in man-evidence for dose dependency and changed pharrna
cokinetics during chronic therapy, Brit. J. Clin. Pharm. 12
(1981) 653-658]. A currently marketed loWest dose cloni
dine patch delivers 4.32 pg/h from a 3.5 cm2 patch, or 1.2
pg/cm2~hr [Toon et al., Rate and extent of absorption of
clonidine from a transdermal therapeutic system, J. Pharm.
and Pharmacol. 41 (1989) 17-21]. Flux values for clonidine
in human skin are reported as high as 3.3 pg/cm2~hr [Wang
et al., Permeation studies of clonidine through skins and
different arti?cial membranes, Zhongua Yaoxue Zazhi 45

St. Albans, VT); (2) a polyurethane membrane (MEDI
FILM® 437); (3) an ethyl vinyl acetate membrane (MEDI
FILM® 500); and (4) a polyether block amide membrane

HPLC as described in Example 1. Results are presented in
Table 1.
50

minutes, Which is important for the breakthrough pain

TABLE 1

treatment increase in delivery rates [Roy et al., Transderrnal

delivery of narcotic analgesics: pH, anatomical, and subject

Nicotine ?ux rates for combinations of polymer membranes and
pressure sensitive adhesives.

in?uences on cutaneous permeability of fentanyl and sufen

tanil, Pharm. Res. 7 (1990) 842-847]. Breakthrough cancer

55

pain can be treated With a fentanyl nasal spray at a dose of

20 pg, Which results in analgesia Within 10 minutes [Zep

petella, G., An assessment of the safety, e?icacy, and accept
ability of intranasal fentanyl citrate in the management of
cancer-related breakthrough pain: a pilot study, J. Pain and

60

Symptom Management 20 (2000) 253-258]. Breakthrough
cancer pain is often treated With a 200 pg fentanyl loZenge

so the delivery of 100 pg over 10 minutes Would be a

mg/cm2~hr). Maximum ?ux rates of fentanyl across human

MEDIFILM
87-900A
MEDIFILM
MEDIFILM
MEDIFILM
MEDIFILM
MEDIFILM

Skin only

(ACTIQ®) in patients already under treatment With opioids.
The buccal bioavailability of this fentanyl loZenge is 50%,

reasonable transdermal delivery goal for pain bouts (0.6

Polymer membrane/adhesive

65

Flux rate (pInol/cm2.hr)

® 840/DURO-TAK ®

19.3 r 2.9

®
®
®
®
®

9.7
8.7
17.2
12.1
18.8

840/BIO-PSA
SOO/BIO-PSA
390/BIO-PSA
437/BIO-PSA
437/BIO-PSA

®
®
®
®
®

7-4303
7-4303
7-4303
7-4303
7-4606

r
r
r
r
r

2.2
6.2
4.9
0.9
5.1

31.4 r 9.3

These results indicated that the combinations of a poly
ether block amide membrane/acrylic pressure sensitive
adhesive Without functional groups, polyether block amide

US 7,229,556 B1
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membrane/silicone pressure sensitive amine-compatible
adhesive, and polyurethane membrane/silicone pressure
sensitive standard adhesive provided acceptable ?ux rates

To address this need, a gateable ordered nanoporous mem

brane is provided herein, Wherein the pores of the membrane
can be selectively exposed or occluded.
The nanotubules forming the membrane pores may be

for nicotine. HoWever, it Was noted that all polymer mem
branes evaluated provided ?ux rates for nicotine that Were
Well in excess of the maximum required delivery rate of 4
p.mol/cm2~hr as has been found desirable in a conventional

functionaliZed at the tip With charged functional groups. As

has been previously described (U .S. patent application Ser.
No. 11/128,443), in the embodiment of the ordered nanotu

nicotine cutaneous patch as previously discussed. Therefore,
the supplemental polymer membranes are not expected to
contribute appreciably to variation in ?ux rate.
It Will be appreciated also by the skilled artisan that the
selection of combinations of polymer membranes/ adhesives

bule membrane of the present invention comprising aligned
carbon nanotubes in a polymer matrix (Example 1), the
carbon nanotubes are conductive, While the polymer matrix

(in the described embodiment, polystyrene) may be insulat
ing. It Will be appreciated that placing a charged functional
group adjacent to the nanotubule pore (attached thereto by

for use in a cutaneous delivery system Will be dictated by the

properties of the compositions to be passed therethrough,
i.e., by the desired ?ux rate for the particular compositions,
the propensity of the composition to interact With the
polymer and/or the adhesive, and the like. Such evaluations
are Well Within the knowledge possessed by the skilled
artisan.
20

EXAMPLE 3

positive bias, depending on Whether the charged functional

Next, a delivery system adaptable for cutaneous delivery

group used is positively or negatively charged, to achieve
the desired attraction or repulsion from the nanotubule Wall.

Was evaluated, comprising the ordered nanoporous mem

brane of Example 1 as the rate-controlling component and

25

the polymer/ adhesive supplemental membrane of Example 2
as a protective mechanism to reduce risk of biofouling of the
ordered nanoporous membrane. A non-functionaliZed CNT

membrane prepared substantially as described in Example 1
Was adhered to MEDIFILM® 840 using DURO-TAK®
87-900A. The composite membrane Was placed into a

30

?ow-through diffusion cell and evaluated for nicotine trans
port as described in Example 2. Polymer/ skin patches (With

Because the polymer matrix is insulating, the applied bias
or electrical impulse Would be applied only to the nanotu
bule. This provides the further bene?t of being able to isolate
the applied electrical impulse to the pores of the ordered
nanoporous membrane, rather than to the entirety of the
membrane and/ or the surface to Which the composition is to
be delivered. This phenomenon is often seen With conven

tional non-invasive programmable drug delivery methods
such as iontophoresis, electroporation, and the like, resulting

out CNT membranes) Were used as controls.

As shoWn in FIG. 2, the nicotine ?ux from the CNT
membrane/polymer membrane/ skin patches Was 8-fold less
than nicotine ?ux from the polymer membrane/ skin patches.
A good linear steady-state diffusion pro?le Was obtained
With the CNT membrane/polymer membrane/ skin patches

35

over a 24 hr period, and the membrane Was intact and

40

in undesirable skin irritation and/or disruption of the skin
barrier.
EXAMPLE 4
An ordered nanotubule membrane Was fabricated sub

stantially as described in Example 1, for use in evaluation of
use of charged molecules for selective exposing/occlusion of

undamaged at the end of the experiment (not shoWn).
Nicotine ?ux from the membrane Was 0.90 umol/cm2~hr,
Well Within a desirable delivery range for nicotine of 008-4

p.mol/cm2~hr.
Accordingly, the present Work demonstrates that the

the same amide chemistry as previously described herein,
see Example 1, or by any other suitable method) alloWs use
of electrostatic capacitance to draW the charged group
toWards the conductive nanotubule Wall or to repel the
charged group therefrom, occluding or exposing the nano
tubule pore as shoWn schematically in FIG. 3. Of course, the
electrical impulse applied Will be either a negative bias or a

45

the pores of the membrane. Apolypeptide tether (see FIG. 4)
Was used to bond charged dye molecules (Direct Blue 71;
Aldrich) adjacent the nanotubule pores using the carboimide

ordered nanoporous membranes of this invention can be

chemistry substantially as described herein and in US.

adapted as components of a patch for delivery of a compo
sition to a surface such as skin. It Will be appreciated that,

patent application Ser. No. 11/128,443. Brie?y, dye Was

based on knoWn physicochemical properties of composi
tions adaptable for delivery by a cutaneous patch, properties
of the patches can be optimiZed for speci?c delivery rates of

added to a 4 ml solution of 0.1 M MES to make a 50 mM

solution. Eight mg of 1-[3-(Dimethylamino)propyl]-3ethyl
50

the drug of choice. In cases Where the ?ux value for a
particular composition intended to be provided as a trans
dermal formulation is less than desired for a predetermined

transdermal delivery rate, penetration enhancers such as

temperature, folloWed by Washing With MES buffer and
isopropyl alcohol to remove excess reagents.
55

compositions to improve delivery rate.
For complicated dosage regimens such as that described
herein for clonidine, and also for intermittent dosage regi

permeation set-up Were maintained at the same level to
60

desired to provide drug delivery “peaks” interspersed With
address intermittent events such as nicotine craving or

than constant delivery at a predetermined ?ux rate over time.

prevent pressure-induced transport. Methyl viologen dichlo
ride hydrate (methylviologen2+; Aldrich) Was the probe
molecule. The permeate Was periodically pipetted out, tested
for presence of probe molecule by UV-vis spectroscopy (HP
8543 Spectrophotometer), and then transferred back to the

intervening periods of reduced or no drug delivery (to
breakthrough pain, for example), it is desirable to adapt a
cutaneous delivery system as described in the foregoing
disclosure for selective delivery of a composition, rather

Flux through the functionaliZed membrane Was evaluated

using a U-tube permeation experiment substantially as
described in Example 1. Liquids in the tWo chambers of the

ethanol, oleic acid, or other surfactants may be added to the

mens for drugs such as nicotine or fentanyl Wherein it is

carbodiimide hydrochloride (EDC) Was dissolved in the
solution, folloWed by immersion of the nanotubule mem
brane therein. The reaction proceeded for 12 hr at ambient

65

chamber. A peak detected at 260 mm Was used to quantify
the amount of methylviologen2+. A calibration curve Was

determined by ?tting non-linear (to account for the non
linear deviation from Lambert-Beer’s LaW in higher con

US 7,229,556 B1
11

12

centrations of analyte) curves to plots of absorbance vs.

transdermal systems can be used for delivery of the com

conceptration of the analyte in the range 5*10‘4 (M) to
1*10 (M).
As shown in FIG. 5, the ?ux of methylviologen2+ through

positions, such as mineral oil, propylene glycol, and ethanol.
Since the membrane of the present invention has a surface

resistance of 0.32/Qcm, it is Well Within the knoWledge
expected of the skilled artisan to determine the optimal ionic
strength of the composition reference solution to ?nd a

the functionaliZed nanotubule membrane Was altered by

application of an electrical impulse to the dye/polypeptide
functionaliZed nanotubule membrane. A 60% increase in
?ux Was observed from a bias of +50 mV to —30 mV (0.1 M

threshold concentration for ionic interference in an aqueous

solution.
The required bias to attract charged groups into the
nanotubule pores for occlusion thereof can also be estimated

KCl electrolye), clearly demonstrating that the applied bias
modulated chemical ?ux through the membrane of the
present invention.

from electrochemical studies of long-chained charged func
tional group (1 -thioundecanecarboxylic acid) monolayers on
gold electrodes [Krishna et al., Tethered bilayer membranes
containing ionic reservoirs: The interfacial capacitance,

EXAMPLE 5

Referring noW to FIG. 6, a selectively gateable delivery
system 10 is depicted Wherein the nanotubule pore of the
ordered nanoporous membrane is selectively exposed or at
least partially occluded by application of an electrical

Langmuir 17 (2001) 4858-4866]. lnterfacial capacitances

impulse (applied bias) as described in Example 4. The

aligned carbon nanotubes (Example 1) having approxi

delivery system 10, in this embodiment adapted for use as a

have been experimentally measured at from 2.4 uF/cm2 to
1.6 uF/cm2 for solutions of 1 to 1000 mM ionic strength

(NaCl). For nanotubule membranes comprising vertically
20

cutaneous delivery system, comprises a supplemental poly
mer membrane 12, a nanotubule membrane 14 (see Example
1) adhered to the polymer membrane 12, a reservoir 16 for
holding a composition for delivery to a skin surface 18, and
a cover 20. Any suitable fastener or restraint for maintaining

mined by Helmholtz capacitance and the Debye screening
25

contact betWeen the delivery system 10 and an adjacent
surface may also be provided, such as an adhesive, an elastic

loop, ring, or band, fastening tape, a strap, a buckled strap,
a tie, a band secured by hook and loop material, and the like.
For example, the polymer membrane 12 may optionally

mately 20 charged functional groups per carbon nanotube
(1><10l2/cm2) the required bias is 67-100 mV, Which is Well
Within practical limitations.
The structure of the double charge layer is largely deter
length. Mobile ions in solution can reach the interface and
effectively screen the charge on the electrode from the
charged functional group at the end of the tethered func

tional molecule (2-3 nm long). The Debye screening length
in solution is given by the formula:
30

include a pressure sensitive adhesive (see Example 2) on a

margin thereof to maintain the delivery system 10 in contact
With a surface such as skin.

A ?rst contact 22 is placed in electrical communication
With the nanotubule membrane 14, and a second contact 24

35

is placed in electrical communication With the reservoir 16.
An actuator 26 is provided also, in electrical communication
With the ?rst and second contacts 22, 24 via leads 28, 30.

Where E, is the relative dielectric constant of solvent (E,~80

for H2O), T?emperature in Kelvin, kfBoltZman constant,

The cover 20 may be fabricated of any suitable material

providing the desired protective effect. Typically, the cover
20 Will be fabricated of a breathable material, Which pre
vents entry of Water but alloWs escape of Water vapor such
as perspiration, to improve user comfort. The actuator 26
may be as simple as a poWer source (not shoWn) having a
sWitch for alloWing transmission of an electrical current to
the nanotubule membrane 14, or may comprise more com

40

be a variable to be considered. For a 0.01M solution the
45

grammable activation/deactivation of the delivery system
can be achieved are knoWn in the art. For example, the
50

screening Would not be expected to be a factor When using
non-aqueous solvents currently used for transdermal

cutanous patches. The Debye screening length is actually an
upper limit of ionic interference, since studies With poly
electrolyte brushes predict signi?cant contraction in 0.1 M
ionic strength solutions under applied bias using a modi?ed

are typically electrically conductive, Whereas the polymer

matrix is typically electrically insulating. Accordingly, the

Debye length is an acceptable 3 nm. Using a mineral oil
solvent can be expected to reduce E, to approximately 3, and

CS to approximately mM, and accordingly net Debye screen
ing lengths Would be approximately 50 nm. This is Well
beyond the length of the tethered molecule, and ionic

plex control electronics. Suitable actuators by Which pro
actuators described in US. Pat. Nos. 6,539,250 and 6,723,
077, the disclosures of Which are incorporated herein in their
entirety by reference, can be adapted for use in the present
invention. As noted above, the nanotubules of the membrane

and CS is ionic concentration in solution.
In vivo ionic strengths (0.15M) have a Debye length of
0.8 nm, Which is shorter than the length of the tethered
molecule, and therefore ionic interference can be expected to

55

Gouy-Chapman length model [Zhulina et al., Screening

delivery system alloWs isolation of the applied electrical

effects in a polyelectrolyte brush: Self-consistent-?eld

impulse to the nanotubule array of the ordered nanoporous

theory, Macromolecules 33 (2000) 4945-4953]. By varying

membrane, reducing the likelihood of skin irritation, dis
ruption of the skin barrier, and other similar undesirable

ionic strength and E, of the aqueous solution, the present

effects.

60

invention can easily be tailored for use of aqueous solvents
Without ionic interference.

The skilled artisan Will quickly appreciate that the cuta
neous delivery system described herein can be easily modi

It Will be appreciated by the skilled artisan that the
carboimide chemistry described in the foregoing disclosure

?ed for optimal delivery of a variety of compositions, based
on knoWn physicochemical properties of the composition to

can be used to attach a variety of charged functional mol
ecules adjacent the nanotubule pores of the ordered nanopo
rous membrane of the present invention, for use as “gate
keeper” molecules in devices such as a cutaneous patch as
described in Examples 4 and 5. Alternatively, as discussed

be delivered. Particular emphasis is placed on the role of
ionic strength for aqueous solutions placed in the reservoir

16. Alternatively, non-polar solvents commonly used in

65
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The foregoing description of the preferred embodiment of

supra other suitable methods for binding functional mol
ecules adjacent the nanotubule pores may be employed, such
as electrochemical modi?cation. The proviso is that the

this invention has been presented for purposes of illustration
and description. It is not intended to be exhaustive or to limit

molecule must be amino-terminated, and must have a

charged moiety Which causes the molecule to selectively
expose or at least partially occlude the adjacent pore in
response to an applied bias. Examples include, but are not

5

teachings. For example, the method of providing an aligned
array of holloW nanotubules is not limited to the example

described in Example 1. Any suitable method for providing

limited to, amino sulfonates, charged triphenylphospho
nium, and thiol-gold nanocrystal molecules. Polypeptide

an aligned array of nanotubules may be employed, such as
for example embedding nanotubules such as carbon nano
tubes in a porous alumina template. It is also knoWn to groW
carbon nanotubes or other self-assembling nanotubules in
situ in a porous template such as alumina.
Similarly, the additional functional group may be bound
adjacent the nanotubule pore of the ordered nanoporous

tethers may be fabricated using carboimide chemistry to

increase the length of the charged molecule/tether composite
as desired.

EXAMPLE 6

An ordered nanoporous membrane is synthesiZed sub
stantially as described in Example 1. A commercially avail
able long chain amino sulfonate (FIG. 7a) is attached to a
carboxylate group at a nanotubule pore by the depicted
amino group using the carboimide chemistry described in

the invention to the precise form disclosed. Obvious modi
?cations or variations are possible in light of the above

membrane by alternative methods, With the proviso that the
functional groups bind only near the nanotubule tips, rather
than binding further into the interior of the nanotubule
lumen. For example, it is knoWn to electrochemically
20

Example 1.

modify graphitic surfaces to alloW binding of functional
groups. Saby et al. demonstrated electrochemical reduction
of substituted (using a para substituent such as nitro, car

EXAMPLE 7

An ordered nanoporous membrane is synthesiZed sub
stantially as described in Example 1. A commercially avail
able short chain amino sulfonate (FIG. 7b) is attached to a
carboxylate group at a nanotubule pore by the depicted
amino group using the carboimide chemistry described in

Example 1.

25

l. Blocking Effect of 4-Nitrophenyl and 4-Carboxyphenyl
Groups, Langmuir 13, p. 6805-6813 (1997)].
30

EXAMPLE 8

MarWan et al. demonstrated electrochemical grafting of
N,N-Diethylaniline to a glassy carbon electrode, folloWed
by binding a charged copper molecule or Prussian Blue dye,
as Well as modi?cation of a glassy carbon electrode With

An ordered nanoporous membrane is synthesiZed sub
stantially as described in Example 1. Chain lengths are

added to charged triphenylphosphonium by acidic deprotec

boxy, etc.) phenyl diaZonium to form a diaZonium radical,
covalently binding to the surface of a glassy carbon elec
trode, and grafting a correspondingly substituted phenyl
group [see Saby et al., Electrochemical Modi?cation of
Glassy Carbon Electrode Using Aromatic DiaZonium Salts.

4-sulfonate phenyl and binding of charged ruthenium [Mar
35

tion of cyclic acetyl group and reaction With n-amino bromo
alkane (FIG. 70), and the molecule is attached to a carboxy
late group at a nanotubule pore by the depicted amino group

using the carboimide chemistry described in Example 1.
40

EXAMPLE 9

Wan et al., FunctionaliZation of glassy carbon electrodes
With metal-based species, Chem. Mater. 17, pp. 2395-2403

(2005)]. It Will be appreciated that, for example, the ordered
nanoporous membranes of the present invention comprising
carbon nanotubes could be similarly modi?ed to bind func
tional groups. Because only the tips of the carbon nanotubes
extend beyond the surface of the matrix in Which they are
embedded, functional groups Would bind only to the nano

An ordered nanoporous membrane is synthesiZed sub
stantially as described in Example 1. A polypeptide tether
(FIG. 4) is attached to a carboxylate group at a nanotubule

tube tips, and therefore only adjacent the membrane pores.
The embodiment Was chosen and described to provide the
45

pore by the depicted amino group using the carboimide
chemistry described in Example 1. Length of the polypep

in the art to utiliZe the invention in various embodiments and
With various modi?cations as are suited to the particular use

tide tethers is increased as desired by successive carboimide
reactions at a nanotubule (n) entrance. Polypeptide tether

length is controlled by the number of times the terminal
carboxylate on the nanotubule (n) is activated by EDC

50

contemplated. All such modi?cations and variations are
Within the scope of the invention as determined by the

appended claims When interpreted in accordance With the
breadth to Which they are fairly, legally, and equitably

coupling agent, folloWed by placement in 8-amino caprylic
acid (ACA) solution. Charged molecules such as those
depicted in FIGS. 7a-c are coupled to the polypeptide tethers
using the same carboimide chemistry as previously
described.

best illustration of the principles of the invention and its
practical application to thereby enable one of ordinary skill

55

entitled.
What is claimed is:
1. A device for cutaneous delivery of a composition,

comprising:
an ordered nanoporous membrane including a plurality of
aligned holloW nanotubules held in a continuous poly

EXAMPLE 10

mer matrix, the plurality of aligned holloW nanotubules
Referring to FIG. 7d, a charged molecule is attached to a
nanotubule pore carboxylate group by addition of a thiol

60

through the ordered nanoporous membrane; and

(SH) group, folloWed by covalent bonding to a gold nanoc

rystal. Gold nanocrystals are normally anionically charged
to be a stable colloidal system, and therefore the molecule’s
position at the nanotubule pore entrance can be altered from

an occluding position to an open position by electrostatic
force.

having a lumen de?ning at least one pore passing

65

a reservoir for holding the composition, said reservoir in
?uid communication With the ordered nanoporous
membrane.
2. The device of claim 1, Wherein the ordered nanoporous
membrane includes at least one functional unit bound adja
cent to the pore.

US 7,229,556 B1
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3. The device of claim 2, wherein the at least one
functional unit selectively exposes or at least partially
occludes the pore of an adjacent nanotubule.
4. The device of claim 3, Wherein the at least one
functional unit is selected from the group consisting of a

holloW nanotubules, coating the aligned holloW nanotubules
With the continuous polymer matrix to form a membrane,
and etching the membrane to open the plurality of holloW
nanotubules and form pores.

17. The method of claim 16, further including the step of

ligand, a receptor, a receptor-ligand complex, a reversibly

binding at least one functional unit adjacent to the nanotu
bule pore.
18. The method of claim 17, Wherein the at least one
functional unit selectively exposes or at least partially
occludes the pore of an adjacent nanotubule.

binding receptor-ligand complex, a charged molecule, a

binder-ligand complex, a reversibly binding binder-ligand
complex, a ligand adapted for speci?cally binding to a
predetermined target molecule, a hydrophilic molecule, a
hydrophobic molecule, a catalytic coordination compound, a

19. The method of claim 18, including selecting the at

catalytic metal, biotin, avidin, streptavidin, aliphatic amines,
charged dyes, anionically charged ligands, cationically

least one functional unit from the group consisting of a

ligand, a receptor, a receptor-ligand complex, a reversibly

charged ligands, and any combination thereof.

binding receptor-ligand complex, a charged molecule, a

5. The device of claim 3, Wherein the at least one

binder-ligand complex, a reversibly binding binder-ligand

functional unit is selectively displaceable to at least partially
expose or at least partially occlude the pore of an adjacent
nanotubule.
6. The device of claim 5, Wherein the at least one
functional unit includes a charged group.
7. The device of claim 6, Wherein the at least one

complex, a ligand adapted for speci?cally binding to a
predetermined target molecule, a hydrophilic molecule, a
hydrophobic molecule, a catalytic coordination compound, a
20

charged ligands, and any combination thereof.

functional unit is selected from the group of charged groups
consisting of acetate, aluminate, amino sulfonate, ammo

nium, quaternary ammonium, arsenate, aZide, carbonate,
borate, bromate, bromite, carbide, chlorite, chromate,
chromite, cyanate, dichromate, phosphate, phosphite, disul
?de, formate, fulminate, sulfate, sul?de, hydrogen sul?te,

25

least one functional unit from the group consisting of
30

and any combination thereof.

8. The device of claim 6, Wherein the continuous polymer

matrix is electrically insulating.
9. The device of claim 6, Wherein the aligned holloW
nanotubules are electrically conductive.
10. The device of claim 5, further including at least one

35

acetate, aluminate, amino sulfonate, ammonium, quaternary
ammonium, arsenate, aZide, carbonate, borate, bromate,

bromite, carbide, chlorite, chromate, chromite, cyanate,
dichromate, phosphate, phosphite, disul?de, formate, fulmi
nate, sulfate, sul?de, hydrogen sul?te, hydroxide, nitrate,
nitrite, oxalate, pyridinium, pyrophosphate, sul?te, sulfo
nium, tartrate, thiocyanate, thiosulfate, toluenesulfonate,
charged metal coordination compounds, and any combina

contact in electrical communication With the ordered nan
oporous membrane.

tion thereof.

23. The method of claim 21, further including the step of

11. The device of claim 10, further including an actuator
in electrical communication With the at least one contact.

20. The method of claim 18, Wherein the functional unit
is selectively displaceable to at least partially expose or at
least partially occlude the pore of an adjacent nanotubule.
21. The method of claim 20, including selecting a func
tional unit having a charged group.

22. The method of claim 21, including selecting the at

hydroxide, nitrate, nitrite, oxalate, pyridinium, pyrophos
phate, sul?te, sulfonium, tartrate, thiocyanate, thiosulfate,
toluenesulfonate, charged metal coordination compounds,

catalytic metal, biotin, avidin, streptavidin, aliphatic amines,
charged dyes, anionically charged ligands, cationically

40

12. The device of claim 1, Wherein the nanotubules are

providing at least one contact in electrical communication
With the ordered nanoporous membrane.

selected from the group consisting of multi-Walled carbon

24. The method of claim 23, further including the step of

nanotubes, single-Walled carbon nanotubes, self-assembling

providing an actuator in electrical communication With the
at least one contact.

macromolecular tubules comprising peptides and porphy
rins, and any combination thereof.
13. The device of claim 1, further including a fastener for
holding the device adjacent to a surface.
14. The device of claim 13, Wherein the fastener is
selected from the group consisting of an adhesive, a pressure
sensitive adhesive, an elastic band, loop, or ring, a hook and

45

25. The method of claim 21, Wherein the plurality of
aligned holloW nanotubules are electrically conductive.
26. The method of claim 21, Wherein the continuous

polymer matrix is formed of an electrically insulating poly
mer.

50

loop material, a tape, a strap securable by adhesive, hook

27. The method of claim 16, further including the step of
providing a fastener for holding the ordered nanoporous

and loop material, or a buckle, a tie, and any combination
thereof.
15. A method for cutaneous delivery of a composition,

membrane adjacent to a surface.
28. A device for cutaneous delivery of a composition,

comprising:
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providing a reservoir containing the composition in ?uid
communication With an ordered nanoporous membrane

comprising a plurality of holloW nanotubules held in a

continuous polymer matrix, the plurality of holloW
nanotubules having a lumen de?ning at least one pore
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Wherein the ordered nanoporous membrane further
includes at least one functional unit bound adjacent to
a pore de?ned by a lumen of the holloW nanotubule.

and

passing the composition through the ordered nanoporous
oporous membrane is formed by aligning the plurality of

an ordered nanoporous membrane including a plurality of
aligned holloW nanotubules held in a continuous poly
mer matrix; and
a reservoir for holding the composition, said reservoir in
?uid communication With the ordered nanoporous

membrane;

passing through the ordered nanoporous membrane;
membrane.
16. The method of claim 15, Wherein the ordered nan

comprising:
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